These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19193612)

  • 1. Relationships with the drug industry: More regulation, greater transparency.
    Krumholz HM; Ross JS
    BMJ; 2009 Feb; 338():b211. PubMed ID: 19193612
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationships with the drug industry: Keep at arm's length.
    Angell M
    BMJ; 2009 Feb; 338():b222. PubMed ID: 19193614
    [No Abstract]   [Full Text] [Related]  

  • 3. Vermont to require drug makers to disclose payment to doctors.
    Petersen M
    N Y Times Web; 2002 Jun; ():C1, C12. PubMed ID: 12159894
    [No Abstract]   [Full Text] [Related]  

  • 4. MSJAMA: gifts to physicians in the consumer marketing era.
    Steinman MA
    JAMA; 2000 Nov; 284(17):2243. PubMed ID: 11056602
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationships with the drug industry: Build trust based on good science.
    Gottlieb S
    BMJ; 2009 Feb; 338():b234. PubMed ID: 19193616
    [No Abstract]   [Full Text] [Related]  

  • 6. Physician-industry relations--will fewer gifts make a difference?
    Steinbrook R
    N Engl J Med; 2009 Feb; 360(6):557-9. PubMed ID: 19196671
    [No Abstract]   [Full Text] [Related]  

  • 7. US campaign aims to end industry gifts, speaking fees, and travel for doctors.
    Tanne JH
    BMJ; 2007 Feb; 334(7590):385. PubMed ID: 17322228
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical sales reps: value beyond samples.
    Flewell MN
    Adv Nurse Pract; 2006 Jul; 14(7):18. PubMed ID: 16977890
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug company targets US state health officials.
    Moynihan R
    BMJ; 2004 Feb; 328(7435):306. PubMed ID: 14764476
    [No Abstract]   [Full Text] [Related]  

  • 10. Canada lags on transparency of industry-doctor relationships.
    Collier R
    CMAJ; 2013 Apr; 185(6):E245-6. PubMed ID: 23439627
    [No Abstract]   [Full Text] [Related]  

  • 11. Are we providers or physicians?
    Baxter JD
    Arch Intern Med; 2009 Oct; 169(18):1725. PubMed ID: 19822834
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationships between medical students and drug companies in New Zealand.
    Wyber R; Fancourt N; Stone B
    N Z Med J; 2011 Aug; 124(1341):58-64. PubMed ID: 21959637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug industry loses bid to block disclosure of doctors' gifts.
    Burton B
    BMJ; 2007 Jul; 335(7609):12-3. PubMed ID: 17615200
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The invisible influence of industry inducements.
    Rhodes R; Capozzi JD
    Am J Bioeth; 2003; 3(3):65-7. PubMed ID: 14594501
    [No Abstract]   [Full Text] [Related]  

  • 16. Lunch with Lilly: who pays?
    Strong C
    Am J Bioeth; 2003; 3(3):62-3. PubMed ID: 14594499
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancing transparency and efficiency in reporting industry-sponsored clinical research: report from the Medical Publishing Insights and Practices initiative.
    Clark J; Gonzalez J; Mansi B; Miller C; Mooney LA; Mosdell K; Richards D; Schreiweis M; Weigel A; Wager E
    Int J Clin Pract; 2010 Jul; 64(8):1028-33. PubMed ID: 20487047
    [No Abstract]   [Full Text] [Related]  

  • 18. Banning pens and pads misses the main point.
    Terry SF; Burke W
    Am J Bioeth; 2003; 3(3):63-5. PubMed ID: 14594500
    [No Abstract]   [Full Text] [Related]  

  • 19. Orthopaedic surgeons and the medical device industry: the threat to scientific integrity and the public trust.
    Gelberman RH; Samson D; Mirza SK; Callaghan JJ; Pellegrini VD
    J Bone Joint Surg Am; 2010 Mar; 92(3):765-77. PubMed ID: 20194337
    [No Abstract]   [Full Text] [Related]  

  • 20. A higher bar--Vermont's new law on marketing prescribed products.
    Steinbrook R
    N Engl J Med; 2009 Jul; 361(1):8-9. PubMed ID: 19516028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.